News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Englese Thomas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/09/2023 |
4
| Englese Thomas (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Sold 289 shares
@ $4.3, valued at
$1.2k
Exercised 937 restricted stock units
@ $0 |
|
| 09/12/2022 |
4
| Englese Thomas (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Paid exercise price by delivering 4,728 shares
@ $7.3, valued at
$34.5k
Exercised 15,390 restricted stock units
@ $0 |
|
| 03/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/08/2020 |
4
| Englese Thomas (Chief Commercial Officer) has filed a Form 4 on AZIYO BIOLOGICS, INC.|
Txns:
| Granted 33,488 options to buy
@ $17, valued at
$569.3k
Granted 13,890 restricted stock units
@ $0 |
|
| 10/07/2020 |
3
| Englese Thomas (Chief Commercial Officer) has filed a Form 3 on AZIYO BIOLOGICS, INC. |
|
|